Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-10797
Publication type: Article in scientific journal
Type of review: Peer review (publication)
Title: ZHAW Waedenswil : a new approach in the fight against cancer
Authors: Rimann, Markus
DOI: 10.2533/chimia.2018.166
10.21256/zhaw-10797
Published in: Chimia
Volume(Issue): 72
Issue: 3
Pages: 166
Pages to: 168
Issue Date: 2018
Publisher / Ed. Institution: Schweizerische Chemische Gesellschaft
ISSN: 0009-4293
Language: English
Subjects: Alginate; Antineoplastic agent; Biological assay; Biomedical research; Biomedical technology; Glucuronic acid; Hexuronic acid; Human; Lung neoplasm; Mesothelioma; Tumor cell, cultured; Cell culture technique
Subject (DDC): 616: Internal medicine and diseases
Abstract: A happy coincidence brought Dr Markus Rimann from ZHAW W├Ądenswil together with Dr Andreas Meyer from the start-up FGen and PD Dr Emanuela Felley-Bosco, Molecular Oncologist at Zurich University Hospital, to develop a technology platform for the manufacture and high throughput analysis of single mesothelioma spheroids. Armin Picenoni, former student in Chemistry for the Life Sciences at ZHAW, confirmed everything in writing his Master Thesis on this Innosuisse project.
URI: https://digitalcollection.zhaw.ch/handle/11475/10797
Fulltext version: Published version
License (according to publishing contract): CC BY-NC 4.0: Attribution - Non commercial 4.0 International
Departement: Life Sciences and Facility Management
Organisational Unit: Institute of Chemistry and Biotechnology (ICBT)
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
2018_Rimann_ZHAW-Waedenswil-fight-against-cancer.pdf180.89 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.